Report Finds Parent Training Effective for Treating Young Children with ADHD
Electronic Newsletter, Issue 327
An estimated 12.1 million women age 18 and older reported suffering from chronic pain in 2008 as a result of underlying medical conditions such as chronic fatigue syndrome, endometriosis, fibromyalgia and vulvodynia. Of these women, only 8.7 million reported receiving treatment that year at a total cost of $12.9 billion. [Source: Agency for Healthcare Research and Quality, MEPS Statistical Brief #342: Health Care Use and Expenditures for Pain Conditions among Women 18 and Older, U.S. Civilian Noninstitutionalized Population, 2008.
- Report finds parent training effective for treating young children with ADHD
- AHRQ's Effective Health Care Program releases an update on comparing osteoarthritis pain medication
- AHRQ's Effective Health Care Program releases an update on comparing treatments for hypertension
- AHRQ seeks data submissions for medical office survey on Patient Safety Culture Comparative database through October 31
- AHRQ releases HCUP Facts and Figures report with 2009 hospital inpatient data
- New Data Points reports available on anticancer biologic products among Medicare beneficiaries
- Highlights from most recent monthly newsletter
- FDA initiative on preventing surgical fires
- Researching implementation and change while improving quality
- AHRQ in the professional literature
1. Report Finds Parent Training Effective for Treating Young Children with ADHD
Formal training in parenting strategies is a low-risk, effective method for improving behavior in preschool-age children at risk for developing attention deficit hyperactivity disorder (ADHD), while there is less evidence supporting the use of medications for children younger than 6 years old, according to a new AHRQ report. The report found that formal parenting interventions—known as parent behavior training or PBT—are supported by strong evidence for effectiveness for children younger than the age of 6, with no reports of complications or harms. However, one large barrier to the success of PBT occurs when parents drop out of therapy programs, the report found. For children older than age 6, the report found that methylphenidate (sold under the brand name Ritalin) and another drug used to treat ADHD symptoms, atomoxetine (sold as Strattera), are generally safe and effective for improving behavior, but their effects beyond 12 to 24 months have not been well studied. Little information is available about the long-term effects of other medications used to treat ADHD symptoms. The report, "Attention Deficit Hyperactivity Disorder: Effectiveness of Treatment in At-Risk Preschoolers; Long-Term Effectiveness in All Ages; and Variability in Prevalence, Diagnosis, and Treatment," was prepared for AHRQ's Effective Health Care Program by the McMaster Evidence-based Practice Center in Hamilton, Ontario. Select to access the report and select to read our press release.
2. AHRQ's Effective Health Care Program Releases an Update on Comparing Osteoarthritis Pain Medications
AHRQ has released an updated review that compares the effectiveness and safety of pain medications in the treatment of osteoarthritis. The update finds no clear differences in effectiveness of different NSAIDs, but identified potentially important differences in the risk of serious harm. Surveys indicate that 5 to 17 percent of U.S. adults have symptomatic osteoarthritis of the knee, and 9 percent have symptomatic osteoarthritis of the hip. Comparative Effectiveness and Safety of Analgesics for Osteoarthritis—An Update of the 2006 Report includes new research that better addresses the comparative effectiveness and safety of oral and topical medications for osteoarthritis.
3. AHRQ's Effective Health Care Program Releases an Update on Comparing Treatments for Hypertension
A new, updated research review concludes that there is not enough evidence to determine whether there are long-term differences in health outcomes associated with the use of three leading hypertension treatments—ACEIs, ARBs, and direct renin inhibitors—and calls for further research in the field. Nearly 75 million American adults—approximately one third—have hypertension. Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), and Direct Renin Inhibitors for Treating Essential Hypertension is an update to a 2007 AHRQ review on the same topic.
4. AHRQ Seeks Data for Medical Office Survey on Patient Safety Culture Comparative Database Through October 31
AHRQ's Medical Office Survey on Patient Safety Culture is a tool for medical offices to use to assess provider and staff opinions about the culture of patient safety in their medical offices. Medical offices that have administered the AHRQ survey can register and submit their data to the new Medical Office Survey on Patient Safety Culture comparative database through October 31. The database is a central repository for survey data from medical offices, health care systems, or survey vendors that have administered the AHRQ medical office survey instrument. One of the purposes of the database is to produce comparative results to help medical offices identify strengths and opportunities for improvement in their patient safety culture. Select for more information on the benefits of participation and database products, participation requirements, and registration/data submission timeline and activities.
5. AHRQ Releases HCUP Facts and Figures Report with 2009 Hospital Inpatient Data
AHRQ has released the fifth annual edition of the HCUP Facts and Figures report. HCUP Facts and Figures: Statistics on Hospital-Based Care in the United States, 2009 presents information on inpatient hospital care in 2009 and contains comparisons and trends since 1997. The report is organized around high-interest topics, such as hospital and discharge characteristics, diagnoses, procedures, costs and payers. This year's report features a special section on women's health, detailing differences by gender and over time.
6. New Data Points Reports Available on Anticancer Biologic Products Among Medicare Beneficiaries
Two new Data Points reports on anticancer biologic products among Medicare beneficiaries are available from AHRQ's Effective Health Care Program. Data Points #6: Utilization and cost of anticancer biologic products among Medicare beneficiaries, 2006-2009, examines utilization and costs of the anticancer biologics within Medicare Parts A, B, and D claims: monoclonal antibodies, kinase inhibitors, biologic response modifiers, other immunomodulators, other immu-nosuppressives, and miscellaneous biologic nonblood products. Data Points #7: Utilization of anticancer biologic products among Medicare beneficiaries, by diagnostic cancer subchapter, 2006-2009, examines the types of cancer for which anticancer biologics are used, as identified in Medicare Parts B and D claims. This continuing series of reports, published by the DEcIDE (Developing Evidence to Inform Decisions about Effectiveness) Network provides new information and insights into the use of health care services and interventions for the treatment, management, and diagnosis of specific diseases. It also highlights the variations and potential disparities in health care services across patient subpopulations. Select to access these Data Points reports.
7. Highlights from Most Recent Monthly Newsletter
The October issue of Research Activities is available online. Key articles include:
Simpler drug warning labels are easier to understand.
Many drugs are off limits to pregnant women because they can harm fetuses. But not all drug labels state this warning clearly enough for some women to understand it. When researchers tested the standard drug label that warns pregnant women to avoid a drug against a new text version and a text-and-icon version of the label, most women best understood the combination version.
Select to read this article.
Other articles include:
- Study identifies fractures most and least likely to be caused by osteoporosis.
- Patients with type 2 diabetes express mixed reactions to a mobile phone and Web-based disease management program.
- Women on Medicare with poor chances of living 4 more years often forego screening mammograms.
Select to read these articles and others.
8. FDA Initiative on Preventing Surgical Fires
FDA and its partners have launched an initiative and website to increase awareness of factors that contribute to surgical fires, to disseminate surgical fire prevention tools, and to promote the adoption of risk reduction practices throughout the health care community. Seledt for more information on the Preventing Surgical Fires initiative.
9. Researching Implementation and Change While Improving Quality
AHRQ has issued a fact sheet on grant awards (R18) in Fiscal Years (FY) 2009, 2010, and 2011 for demonstration projects focused on the implementation of quality improvement strategies, related organizational changes, and the impact of these strategies and changes. Select to access the fact sheet.
10. AHRQ in the Professional Literature
We are providing the following hyperlinks to journal abstracts through PubMed® for your convenience. Unfortunately, some of you may not be able to access the abstracts because of firewalls or specific settings on your individual computer systems. If you are having problems, you should ask your technical support staff for possible remedies.
Schiff GD, Galanter WL, Duhig J, et al. Principles of conservative prescribing. Arch Intern Med 2011 Jun 13. Select to access the abstract on PubMed.®
Bishop TF, Ryan AK, Casalino LP. Paid malpractice claims for adverse events in inpatient and outpatient settings. JAMA 2011 Jun 15; 305(22):2427-31. Select to access the abstract on PubMed.®
Boelig MM, Streiff MB, Hobson DB, et al. Are sequential compression devices commonly associated with in-hospital falls? A myth-busters review using the Patient Safety Net database. J Patient Saf 2011 Jun; 7(2):77-9. Select to access the abstract on PubMed.®
Trogdon JG, Finklestein EA, Feagan CW, Cohen JW. State- and payer-specific estimates of annual medical expenditures attributable to obesity. Obesity 2011 Jun 16. Epub ahead of print. Select to access the abstract on PubMed.®
Kozhimannil KB, Trinacty CM, Huskamp HA, et al. Racial and ethnic disparities in postpartum depression care among low-income women. Psychiatr Serv 2011 Jun; 62(6):619-25. Select to access the abstract on PubMed.®
Hafner JM, Williams SC, Koss RG, et al. The perceived impact of public reporting hospital performance data: interviews with hospital staff. Int J Qual Health Care 2011 Aug 12. [Epub ahead of print] Select to access the abstract on PubMed.®
Please address comments and questions regarding the AHRQ Electronic Newsletter to Nancy Comfort at Nancy.Comfort@ahrq.hhs.gov or (301) 427-1866.
If you have questions about AHRQ's activities, please try to find the answers by checking our Home Page, where we have established links to various topical areas. Also check the News & Information section and Frequently Asked Questions. You may also Browse the Web Site. These features are designed to assist you in obtaining the information you are seeking.
This service is provided to you at no charge by the Agency for Healthcare Research and Quality AHRQ).